Healthcare Services

Cancer Biopsy Market Revenue Expected to Reach $53.38 Billion by 2030 with 13.3% CAGR

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cancer Biopsy Market In 2026 And What Value Is Projected For 2030?

The market size for cancer biopsies has observed rapid expansion in recent years. This market is forecasted to grow from $28.52 billion in 2025 to $32.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.6%. The historical growth can be ascribed to the escalating global incidence of cancer, the broadening of diagnostic imaging facilities, the widespread adoption of tissue biopsy as a standard diagnostic procedure, the expansion of pathology laboratory networks, and continuous improvements in biopsy device technologies.

The cancer biopsy market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $53.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.3%. This surge is primarily driven by heightened demand for precise oncology diagnostics, the growing embrace of liquid biopsy testing, the broadening scope of personalized cancer treatment strategies, increased investments in molecular diagnostics, and a sharper focus on screening for early-stage cancer. Key developments during this period are expected to encompass the wider implementation of liquid biopsy methods, an uptick in image-guided biopsy procedures, the increasing incorporation of molecular pathology testing, the proliferation of minimally invasive biopsy devices, and an intensified emphasis on discovering cancer at its initial stages.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19355&type=smp

What Key Drivers Are Influencing The Growth Of The Cancer Biopsy Market?

The growing incidence of cancer is anticipated to boost the expansion of the cancer biopsy market in the future. Cancer constitutes a complex collection of diseases defined by the irregular proliferation and spread of cells. The rise in cancer prevalence is attributed to multiple factors, such as lifestyle alterations and urbanization, environmental pollution, tobacco and alcohol intake, and access to healthcare and awareness. A cancer biopsy is utilized to diagnose and assess the cancer type, stage, and spread by extracting and analyzing tissue or cells from a suspicious region. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected over 35 million new cancer cases by 2050, marking a 77% increase relative to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer acts as a driving force for the cancer biopsy market.

What Are The Key Segments Of The Cancer Biopsy Market?

The cancer biopsy market covered in this report is segmented –

1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types

2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications

3) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Tissue Biopsies: Core Needle Biopsies, Fine Needle Aspiration (FNA) Biopsies, Incisional Biopsies, Excisional Biopsies

2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis, Circulating Tumor DNA (ctDNA) Testing, Plasma Biomarker Testing

3) By Other Types: Bone Biopsies, Endoscopic Biopsies, Brush Biopsies, Skin Biopsies

What Key Trends Are Influencing The Development Of The Cancer Biopsy Market?

Major companies operating in the cancer biopsy market are focused on developing liquid biopsy techniques. These advancements aim to facilitate non-invasive, early detection and monitoring of cancer, improve patient outcomes, and enable more personalized treatment strategies. Liquid biopsy is an advanced, non-invasive diagnostic method that identifies and analyzes genetic material from a blood sample, including circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. For example, in May 2023, Labcorp, a US-based company specializing in the manufacturing of cancer biopsies, introduced Labcorp Plasma Focus, a plasma-centric liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) released from tumor cells into the bloodstream, allowing for the construction of a genomic profile of the patient’s tumor and the identification of mutations across 33 genes linked to various cancers, such as non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

Who Are The Leading Companies Operating In The Cancer Biopsy Market?

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

Read the full cancer biopsy market report here:

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Cancer Biopsy Market?

North America was the largest region in the cancer biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cancer Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19355&type=smp

Browse Through More Reports Similar to the Global Cancer Biopsy Market 2026, By The Business Research Company

Anorectal Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

Oncology Nutrition Global Market Report

https://www.thebusinessresearchcompany.com/report/oncology-nutrition-global-market-report

Progressive Ataxia And Weakness Disorders Global Market Report

https://www.thebusinessresearchcompany.com/report/progressive-ataxia-and-weakness-disorders-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795